Literature DB >> 24615705

Nociception specific supraorbital nerve stimulation may prevent cluster headache attacks: serendipity in a blink reflex study.

Danielle Y P Haane1, Peter J Koehler2.   

Abstract

BACKGROUND: In cluster headache, neuromodulation is offered when patients are refractory to pharmacological prophylaxis. Non-invasive peripheral neuromodulatory approaches are of interest. We will focus on these and particularly on nociception specific, transcutaneous supraorbital nerve stimulation.
METHODS: In a study using the nociception specific blink reflex, we made a serendipitous discovery, notably the potential prophylactic effect of bilateral, time contingent, nociception specific, transcutaneous stimulation of the supraorbital nerve.
RESULTS: We report on a case series of seven cluster headache patients, in whom attacks seemed to disappear during repeated stimulation of the supraorbital nerves. Three patients stopped experiencing attacks since study participation.
CONCLUSIONS: Bilateral, time contingent, nociception specific, transcutaneous supraorbital nerve stimulation may have a prophylactic effect in episodic and chronic cluster headache. Given its limited side effects and its non-invasive nature, further studies to investigate this potential peripheral neuromodulatory approach for both episodic and chronic cluster headache are warranted. © International Headache Society 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Cluster headache; blink reflex; neurostimulation; peripheral nerve stimulation; supraorbital nerve stimulation

Mesh:

Year:  2014        PMID: 24615705     DOI: 10.1177/0333102414526055

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  1 in total

1.  High-flow oxygen therapy in cluster headache patients has no significant effect on nociception specific blink reflex parameters: a pilot study.

Authors:  D Y P Haane; A Plaum; P J Koehler; M P W A Houben
Journal:  J Headache Pain       Date:  2016-02-12       Impact factor: 7.277

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.